UBS Asset Management Americas Inc. lifted its holdings in shares of athenahealth, Inc. (NASDAQ:ATHN) by 33.2% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 30,536 shares of the health services provider’s stock after acquiring an additional 7,605 shares during the period. UBS Asset Management Americas Inc. owned 0.08% of athenahealth worth $4,292,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Scout Investments Inc. grew its stake in athenahealth by 67.2% during the 2nd quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock worth $16,256,000 after buying an additional 46,507 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in athenahealth by 1.7% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 72,918 shares of the health services provider’s stock worth $10,249,000 after buying an additional 1,222 shares during the last quarter. Schwab Charles Investment Management Inc. grew its stake in athenahealth by 6.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 170,978 shares of the health services provider’s stock worth $24,031,000 after buying an additional 9,960 shares during the last quarter. BlackRock Inc. grew its stake in athenahealth by 30,642.6% during the 1st quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Finally, State Street Corp grew its stake in athenahealth by 3.7% during the 1st quarter. State Street Corp now owns 502,823 shares of the health services provider’s stock worth $56,662,000 after buying an additional 17,718 shares during the last quarter.

Shares of athenahealth, Inc. (NASDAQ:ATHN) opened at 123.41 on Tuesday. The stock has a market capitalization of $4.93 billion, a P/E ratio of 156.61 and a beta of 1.76. athenahealth, Inc. has a 1-year low of $90.11 and a 1-year high of $158.66. The company has a 50 day moving average price of $130.54 and a 200-day moving average price of $130.09.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The business had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. During the same period in the prior year, the company posted $0.34 EPS. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. On average, equities research analysts forecast that athenahealth, Inc. will post $1.91 EPS for the current fiscal year.

In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $143.31, for a total transaction of $573,240.00. Following the completion of the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at approximately $45,831,541.17. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Daniel P. Haley sold 1,583 shares of the stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $124.56, for a total value of $197,178.48. Following the transaction, the insider now directly owns 13,408 shares of the company’s stock, valued at $1,670,100.48. The disclosure for this sale can be found here. Insiders sold a total of 16,505 shares of company stock valued at $2,240,851 over the last three months. Corporate insiders own 3.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “athenahealth, Inc. (ATHN) Shares Bought by UBS Asset Management Americas Inc.” was posted by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/10/10/athenahealth-inc-athn-shares-bought-by-ubs-asset-management-americas-inc.html.

A number of research analysts recently issued reports on the company. Piper Jaffray Companies restated a “buy” rating and set a $152.00 price target on shares of athenahealth in a research note on Friday, July 14th. Oppenheimer Holdings, Inc. raised their price target on athenahealth from $154.00 to $184.00 and gave the stock an “outperform” rating in a research note on Friday, July 21st. Wells Fargo & Company restated an “outperform” rating and set a $190.00 price target (up previously from $130.00) on shares of athenahealth in a research note on Saturday, July 22nd. BidaskClub downgraded athenahealth from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Finally, Citigroup Inc. restated a “buy” rating and set a $169.00 price target (up previously from $163.00) on shares of athenahealth in a research note on Monday, July 10th. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and twelve have assigned a buy rating to the company. athenahealth presently has an average rating of “Hold” and a consensus price target of $149.91.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.